ISDA

Deposition Date 2018-11-28

Release Date 2019-11-06

Last Version Date 2023-10-11

Entry Detail

PDB ID:

6N7Z

Keywords:

TRANSFERASE/TRANSFERASE INHIBITOR

Title:

Crystal structure of human FPPS in complex with an allosteric inhibitor YF-02037

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.55 Å

R-Value Free:

0.28

R-Value Work:

0.23

R-Value Observed:

0.23

Space Group:

P 41 21 2

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Farnesyl pyrophosphate synthase
Gene (Uniprot):FDPS
Chain IDs:A (auth: F)
Chain Length:375
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P14324 Pfam ID:PF00348 EC:2.5.1.1

Ligand Molecules

GOL

KF7

Primary Citation

Chirality-Driven Mode of Binding of alpha-Aminophosphonic Acid-Based Allosteric Inhibitors of the Human Farnesyl Pyrophosphate Synthase (hFPPS).

Feng, Y, Park, J, Li, S.G, Boutin, R, Viereck, P, Schilling, M.A, Berghuis, A.M, Tsantrizos, Y.S.Show

J.Med.Chem. 62 9691 9702 (2019)

PMID: 31577901 DOI: 10.1021/acs.jmedchem.9b01104

Abstact

Thienopyrimidine-based allosteric inhibitors of the human farnesyl pyrophosphate synthase (hFPPS), characterized by a chiral α-aminophosphonic acid moiety, were synthesized as enantiomerically enriched pairs, and their binding mode was investigated by X-ray crystallography. A general consensus in the binding orientation of all (R)- and (S)-enantiomers was revealed. This finding is a prerequisite for establishing a reliable structure-activity relationship (SAR) model.

Legend

Protein

Chemical

Disease

Primary Citation of related structures